Latest filing published 05 Jan 2016 for ARIAD PHARMACEUTICALS INC.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Harvey J. M. D. Berger: trading record in brief
Harvey J. M. D. Berger discloses dealings in Ariad Pharmaceuticals Inc to SEC (Form 4). In total, 130 filings cover trades dated from 10 March 2006 to 31 December 2015.
Market trades split into 15 purchases (€3.0M) and 20 sales (€9.3M). The net balance comes to €6.4M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 30 share grants and 39 option exercises.
A typical purchase (the median) is worth €61k.
The record was last updated on 5 January 2016 with an option exercise in Ariad Pharmaceuticals Inc. The clock since the last published purchase (13 February 2015) now reads 4,286 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Harvey J. M. D. Berger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 36,000 sharesCommon StockSEC:0001127602-16-036018:0
- 16,992 sharesCommon StockSEC:0001127602-16-036018:1
- 345,000 sharesCommon StockSEC:0001127602-16-036018:2
- 162,841 sharesCommon StockSEC:0001127602-16-036018:3
- 47,500 sharesCommon StockSEC:0001127602-16-036018:4
- 22,420 sharesCommon StockSEC:0001127602-16-036018:5
- 174,000 sharesCommon StockSEC:0001127602-16-036018:6
- 82,128 sharesCommon StockSEC:0001127602-16-036018:7
- 47,500 shares0Common StockSEC:0001127602-15-027701:0
- 36,800 shares0Common StockSEC:0001127602-15-022957:0
- 17,370 shares@ US$8.35Common StockSEC:0001127602-15-022957:1
- 26,454 shares@ US$7.56Common StockSEC:0001127602-15-012775:0
- 24,479 shares@ US$8.17Common StockSEC:0001127602-15-012775:1
- 12,544 shares@ US$7.56Common StockSEC:0001127602-15-012775:2
- 111,002 shares@ US$7.56Common StockSEC:0001127602-15-012775:3
- 102,715 shares@ US$8.17Common StockSEC:0001127602-15-012775:4
- 36,000 shares0Common StockSEC:0001127602-15-012355:0
- 34,000 shares0Common StockSEC:0001127602-15-012355:1
- 12,500 shares@ US$6.77Common StockSEC:0001127602-15-006015:0Canonical exit: 12 May 2015 (T+90)
- 12,500 shares@ US$6.90Common StockSEC:0001127602-15-006015:1Canonical exit: 13 May 2015 (T+90)
- 87,000 shares0Common StockSEC:0001127602-15-004330:0
- 12,500 shares@ US$6.16Common StockSEC:0001127602-15-002793:0Canonical exit: 22 Apr 2015 (T+90)
- 12,500 shares@ US$6.18Common StockSEC:0001127602-15-002793:1Canonical exit: 23 Apr 2015 (T+90)
- 12,500 shares@ US$6.15Common StockSEC:0001127602-14-035729:0Canonical exit: 17 Mar 2015 (T+90)
- 12,500 shares@ US$6.54Common StockSEC:0001127602-14-035729:1Canonical exit: 18 Mar 2015 (T+90)
25 of 128 declarations
